# Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)

Source: https://welltoldgrants.com/grants/par-23-063-limited-competition-renewal-of-centers-of-biomedical/  
Official notice: https://www.grants.gov/search-results-detail/345025

> National Institutes of Health offered grants of up to $1.5 million to small businesses. Applications closed on May 28, 2025.

| Field | Value |
|---|---|
| Opportunity number | PAR-23-063 |
| Agency | National Institutes of Health |
| Status | Forecast |
| Deadline | May 28, 2025 |
| Award ceiling | $1.5 million |
| Award floor | not stated |
| Expected awards | not stated |
| Total funding | not stated |
| Cost sharing | not required |
| Assistance Listings | 93.859 |

## Who can apply

- Small businesses

Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. See full Funding Opportunity Announcement for additional details on eligibility

## What the grant funds

The Centers of Biomedical Research Excellence (COBRE) program supports the establishment and development of innovative biomedical and behavioral research centers at Institutional Development Award (IDeA)-eligible institutions through awards for three sequential five-year phases. The purpose of the COBRE Phase 2 award is to strengthen successful COBRE Phase 1 centers established in Phase 1 through further improvements to research infrastructure and the continued development of a critical mass of investigators with shared scientific interests who are able to compete effectively for independent research funding and further improvements to research infrastructure at the institution.

## Questions people ask

### Is PAR-23-063 still open?

No. It closed on May 28, 2025.

### Who can apply for Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)?

National Institutes of Health accepted applications from small businesses. The notice adds further conditions, so read its eligibility section.

### What is the deadline for Limited Competition: Renewal of Centers of Biomedical Research Excellence (COBRE) (Phase 2) (P20 - Clinical Trial Optional)?

Closed May 28, 2025. Applications are no longer accepted; the program's newer notices are on this page when there are any.

### How much funding is available?

Awards of up to $1.5 million each.

### Who has been funded under PAR-23-063?

NIH RePORTER lists 27 projects funded under PAR-23-063 in fiscal 2024 to 2026, at 26 institutions. The most were at University of Oklahoma HLTH Sciences Ctr, University of Nevada Reno, Mainehealth.

### Who has won Biomedical Research and Research Training grants before?

The largest recipients over five fiscal years were The Leland Stanford Junior University, Regents of the University of Michigan, University of California, San Diego. The program made 11,631 awards worth $15 billion in that time.